India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Infertility: Why do sperm storage before going abroad? The number of people going to work abroad is constantly increasing. This has not only caused the country's manpower to migrate, but has also increased the problem of childlessness. It may sound surprising, but this is today's reality. Most of the men who come to the infertility center say, 'I stayed abroad for a few years for employment. There is no problem with the wife. The child is not being born because of me. Why?' Of course, there are many risk factors for increasing this problem among men living in foreign lands. One of the main ones is temperature. Temperature reduces sperm production. Most of the youth have reached the hot summer area. In this case, the number of people who work at high temperature outside is more. Male sperm production occurs in the testicles outside the body. Therefore, the temperature of the testicles should be at least five degrees lower than the body temperature. Regular and healthy s...